Irene Schilcher is Deputy Head of in vitro research and Project Manager at QPS Austria, department neuropharmacology. QPS Austria is a contract research organization, and the neuropharmacology department focusses on in vitro and in vivo research of neurodegenerative and rare diseases. At QPS Austria, Irene started her career in 2018 as a Preclinical Research Assistant and was quickly promoted to her current position. Irene brings to this position a well-established background in biochemistry and molecular medicine with a Master’s and PhD from the Karl-Franzens University and Medical University of Graz, Austria, respectively. The success of her research efforts can be measured by already nine peer-reviewed scientific publications in the field of Atherosclerosis, Alzheimer’s disease, and Gaucher disease. Furthermore, Irene presented several posters at international scientific neurodegenerative disease-related conferences and two oral presentations at the Austrian Atherosclerosis Society meeting 2017 in Austria and the International Conference on Alzheimer’s and Parkinson’s diseases (AD/PD), 2019 in Portugal. Currently, Irene’s research focusses on protein aggregation in in vitro and in vivo models of neurodegenerative diseases like Tau aggregation in seeding experiments and TDP-43 aggregation in amyotrophic lateral sclerosis.